comparemela.com

Latest Breaking News On - Wiley online library - Page 21 : comparemela.com

ADC Therapeutics Announces Updated LOTIS-2 Results Demonstrating Durable, Long-Term Responses

LAUSANNE, Switzerland, June 09, 2023 (GLOBE NEWSWIRE) ADC Therapeutics SA (NYSE: ADCT) today announced updated results from LOTIS-2, the pivotal Phase 2 clinical trial of ZYNLONTA® (loncastuximab tesirine-lpyl) in

ADC Therapeutics Announces Updated LOTIS-2 Results

Marine Biofouling in Ports: Wet Docks Acting as Hot Spot Biofouling Transfer Stations

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.